🇺🇸 Entecavir Tablet in United States

28 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 5 reports (17.86%)
  2. Blood Uric Acid Increased — 3 reports (10.71%)
  3. Drug Administration Error — 3 reports (10.71%)
  4. Drug Resistance — 3 reports (10.71%)
  5. Hyperthyroidism — 3 reports (10.71%)
  6. Product Storage Error — 3 reports (10.71%)
  7. Blood Creatinine Increased — 2 reports (7.14%)
  8. Blood Urea Increased — 2 reports (7.14%)
  9. Drug Prescribing Error — 2 reports (7.14%)
  10. Musculoskeletal Pain — 2 reports (7.14%)

Source database →

Entecavir Tablet in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Entecavir Tablet approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Entecavir Tablet in United States?

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.